In vitro and in vivo molecular imaging of estrogen receptor α and β homo-and heterodimerization: Exploration of new modes of receptor regulation

Molecular Endocrinology

Volumn 25, Issue 12, 2011, Pages 2029-2040

  Paulmurugan, Ramasamy ^a   Tamrazi, Anobel ^b   Massoud, Tarik F ^c   Katzenellenbogen, John A ^d   Gambhir, Sanjiv S ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; AFIMOXIFENE; DIARYLPROPIONITRILE; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; LIGAND; PIPERIDINE DERIVATIVE; RALOXIFENE; RENILLA LUCIFERIN 2 MONOOXYGENASE;

ARTICLE; DIMERIZATION; GENE CONTROL; GENE INTERACTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIGAND BINDING; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS;

ANIMALS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION; GENES, REPORTER; HEK293 CELLS; HUMANS; LUCIFERASES, FIREFLY; LUCIFERASES, RENILLA; MICE; MICE, NUDE; MOLECULAR IMAGING; PIPERIDINES; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; PYRAZOLES; RALOXIFENE; RECOMBINANT FUSION PROTEINS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TRANSPLANTATION, HETEROLOGOUS;

EID: 82055196856     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1145     Document Type: Article

References (38)

1. Kuiper GG, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138:863-870
2. Mosselman S, Polman J, Dijkema R 1996 ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53
3. Koehler KF, Helguero LA, Haldosén LA, Warner M, Gustafsson JA 2005 Reflections on the discovery and significance of estrogen receptor β. Endocr Rev 26:465-478
4. Harris HA 2007 Estrogen receptor-β: recent lessons from in vivo studies. Mol Endocrinol 21:1-13
5. Minutolo F, Macchia M, Katzenellenbogen BS, Katzenellenbogen JA 2011 Estrogen receptor β ligands: Recent advances and biomedical applications. Med Res Rev 31:364-442
6. Shanle EK, Xu W 2010 Selectively targeting estrogen receptors for cancer treatment. Adv Drug Deliv Rev 62:1265-1276
7. Pettersson K, Gustafsson JA 2001 Role of estrogen receptor β in estrogen action. Annu Rev Physiol 63:165-192
8. Charn TH, Liu ET, Chang EC, Lee YK, Katzenellenbogen JA, Katzenellenbogen BS 2010 Genome-wide dynamics of chromatin binding of estrogen receptors α and β: mutual restriction and competitive site selection. Mol Endocrinol 24:47-59
9. Cowley SM, Hoare S, Mosselman S, Parker MG 1997 Estrogen receptors α and β form heterodimers on DNA. J Biol Chem 272: 19858-19862
10. Pettersson K, Grandien K, Kuiper GG, Gustafsson JA 1997 Mouse estrogen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α. Mol Endocrinol 11:1486-1496
11. Schultz JR, Loven MA, Melvin VM, Edwards DP, Nardulli AM 2002 Differential modulation of DNA conformation by estrogen receptors α and β. J Biol Chem 277:8702-8707
12. Zhao C, Dahlman-Wright K, Gustafsson JA 2008 Estrogen receptor β: an overview and update. Nucl Recept Signal 6:e003
13. Chang EC, Charn TH, Park SH, Helferich WG, Komm B, Katzenellenbogen JA, Katzenellenbogen BS 2008 Estrogen receptorsα andβ as determinants of gene expression: influence of ligand, dose, and chromatin binding. Mol Endocrinol 22:1032-1043
14. Lindberg MK, Movérare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA, Ohlsson C 2003 Estrogen receptor (ER)-β reduces ERα-regulated gene transcription, supporting a "ying yang" relationship between ERα and ERβ in mice. Mol Endocrinol 17:203-208
15. Paulmurugan R, Gambhir SS 2003 Monitoring protein-protein interactions using split synthetic renilla luciferase protein-fragmentassisted complementation. Anal Chem 75:1584-1589
16. Paulmurugan R, Gambhir SS 2005 Firefly luciferase enzyme fragment complementation for imaging in cells and living animals. Anal Chem 77:1295-1302
17. Paulmurugan R, Gambhir SS 2006 An intramolecular folding sensor for imaging estrogen receptor-ligand interactions. Proc Natl Acad Sci USA 103:15883-15888
18. Paulmurugan R, Tamrazi A, Katzenellenbogen JA, Katzenellenbogen BS, Gambhir SS 2008 A human estrogen receptor (ER)α mutation with differential responsiveness to nonsteroidal ligands: novel approaches for studying mechanism of ER action. Mol Endocrinol 22:1552-1564
19. Tamrazi A, Carlson KE, Daniels JR, Hurth KM, Katzenellenbogen JA 2002 Estrogen receptor dimerization: ligand binding regulates dimer affinity and dimer dissociation rate. Mol Endocrinol 16: 2706-2719
20. Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, Katzenellenbogen BS, Katzenellenbogen JA 2000 Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor- α-selective agonists. J Med Chem 43:4934-4947
21. Sun J, Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA, Katzenellenbogen BS 2002 Antagonists selective for estrogen receptor α. Endocrinology 143:941-947
22. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA 2001 Estrogen receptor-β potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44: 4230-4251
23. Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA 2004 Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors α and β. Bioorg Med Chem 12:1559-1567
24. Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA 1999 Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans- 5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes. J Med Chem 42: 2456-2468
25. Massoud TF, Paulmurugan R, Gambhir SS 2010 A molecularly engineered split reporter for imaging protein-protein interactions with positron emission tomography. Nat Med 16:921-926
26. Couse JF, Korach KS 1999 Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20:358-417
27. Paulmurugan R, Umezawa Y, Gambhir SS 2002 Noninvasive im-aging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies. Proc Natl Acad Sci USA 99:15608-15613
28. Eckert RL, Mullick A, Rorke EA, Katzenellenbogen BS 1984 Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique. Endocrinology 114: 629-637
29. Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA, Agard DA, Greene GL 2002 Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat Struct Biol 9:359-364
30. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, SchützG, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
31. Hilal T, Puetter V, Otto C, Parczyk K, Bader B 2010 A dual estrogen receptor TR-FRET assay for simultaneous measurement of steroid site binding and coactivator recruitment. J Biomol Screen 15: 268-278
32. Tamrazi A, Carlson KE, Katzenellenbogen JA 2003 Molecular sensors of estrogen receptor conformations and dynamics. Mol Endocrinol 17:2593-2602
33. Tamrazi A, Carlson KE, Rodriguez AL, Katzenellenbogen JA 2005 Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation. Mol Endocrinol 19:1516-1528
34. Koterba KL, Rowan BG 2006 Measuring ligand-dependent and ligand-independent interactions between nuclear receptors and associated proteins using bioluminescence resonance energy transfer (BRET). Nucl Recept Signal 4:e021
35. Lupien M, Jeyakumar M, Hébert E, Hilmi K, Cotnoir-White D, Loch C, Auger A, Dayan G, Pinard GA, Wurtz JM, Moras D, Katzenellenbogen J, Mader S 2007 Raloxifene and ICI182,780 increase estrogen receptor-α association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12. Mol Endocrinol 21:797-816
36. Powell E, Xu W 2008 Intermolecular interactions identify ligandselective activity of estrogen receptor α/β dimers. Proc Natl Acad Sci U S A 105:19012-19017
37. Paulmurugan R, Gambhir SS 2007 Combinatorial library screening for developing an improved split-firefly luciferase fragment-assisted complementation system for studying protein-protein interactions. Anal Chem 79:2346-2353
38. Paulmurugan R, Massoud TF, Huang J, Gambhir SS 2004 Molecular imaging of drug-modulated protein-protein interactions in living subjects. Cancer Res 64:2113-2119